Article info

Download PDFPDF

Original article
Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial

Authors

  1. Correspondence to Dr Katie Bechman; katie.bechman{at}kcl.ac.uk
View Full Text

Citation

Bechman K, Sin FE, Ibrahim F, et al
Mental health, fatigue and function are associated with increased risk of disease flare following TNF inhibitor tapering in patients with rheumatoid arthritis: an exploratory analysis of data from the Optimizing TNF Tapering in RA (OPTTIRA) trial

Publication history

  • Received February 26, 2018
  • Revision received April 13, 2018
  • Accepted April 15, 2018
  • First published May 17, 2018.
Online issue publication 
May 17, 2018

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.